Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.
Market Cap
$2.53B
P/E Ratio
-20.88
1Y Stock Return
-10.59%
1Y Revenue Growth
20.52%
Dividend Yield
0.00%
Price to Book
0.8
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Current Value
$45.071 Year Return
Current Value
$45.071 Year Return
Yahoo
Wilmington, DE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Jefferies London Healthcare Conference: Matt Trerotola, Chair and Chief Executive Officer, and Ben Berry, Chief Financial Officer, will participate in a fireside chat on Wednesday, November 20th at 12:00 p.m. GMT (7:00 a.m. ET)Evercore 7th Annual HealthCONx Conf
SeekingAlpha
RVT primarily invests in the small-cap space and invests in companies that have strong fundamentals. Find out my recommendation for the fund.
Yahoo
The average of price targets set by Wall Street analysts indicates a potential upside of 39% in Enovis (ENOV). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Yahoo
Enovis Corp (ENOV) reports impressive revenue growth and margin expansion, while navigating integration challenges and market disruptions.
Yahoo
Q3 2024 Enovis Corp Earnings Call
SeekingAlpha
Enovis Corporation (NYSE:ENOV) Q3 2024 Results Conference Call November 6, 2024 8:30 AM ETCompany Participants Kyle Rose - Vice President of Investor...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
XRAY | 62.25% | $3.75B | -39.08% | 3.32% |
NGVT | 58.80% | $1.67B | +18.26% | 0.00% |
SHO | 58.26% | $2.02B | +3.53% | 3.20% |
FRME | 57.99% | $2.51B | +38.53% | 3.21% |
SWK | 57.50% | $13.31B | -3.30% | 3.75% |
SCL | 57.02% | $1.69B | -6.79% | 2.01% |
DGII | 56.65% | $1.14B | +27.53% | 0.00% |
KFRC | 56.52% | $1.10B | -8.71% | 0.66% |
CLDT | 56.36% | $425.53M | -12.03% | 3.24% |
PEB | 56.06% | $1.48B | +0.08% | 0.33% |
ALG | 55.82% | $2.30B | +4.01% | 0.55% |
IEX | 55.23% | $16.93B | +12.60% | 1.21% |
KN | 55.06% | $1.60B | +12.19% | 0.00% |
PK | 55.04% | $2.95B | -0.49% | 11.79% |
NVST | 54.34% | $3.49B | -15.41% | 0.00% |
MCFT | 53.48% | $344.65M | -0.29% | 0.00% |
DRH | 53.39% | $1.86B | +9.28% | 1.35% |
PRO | 53.24% | $1.05B | -39.43% | 0.00% |
RLJ | 53.07% | $1.47B | -7.25% | 4.71% |
BHLB | 53.03% | $1.29B | +44.14% | 2.40% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CORZ | -<0.01% | $4.60B | +3,201.26% | 0.00% |
ZTO | -0.09% | $12.58B | -4.71% | 4.73% |
PDD | 0.17% | $163.43B | +0.29% | 0.00% |
RLMD | -0.55% | $89.92M | +1.36% | 0.00% |
EDU | -0.59% | $9.06B | -22.20% | 0.00% |
SAVA | -0.73% | $1.35B | +25.50% | 0.00% |
BTCT | 0.74% | $42.61M | +353.33% | 0.00% |
IRBT | 0.81% | $220.33M | -75.58% | 0.00% |
HIHO | -0.89% | $8.63M | 0.00% | 6.12% |
NAPA | 0.94% | $1.63B | +9.61% | 0.00% |
OCX | 0.98% | $42.93M | -36.09% | 0.00% |
PRPO | 1.11% | $9.10M | -13.65% | 0.00% |
NERV | 1.12% | $14.69M | -58.00% | 0.00% |
STG | -1.16% | $35.67M | +7.92% | 0.00% |
BACK | 1.31% | $1.76M | -32.90% | 0.00% |
CRCT | 1.40% | $1.12B | -19.90% | 1.91% |
EDSA | 1.46% | $7.11M | -21.79% | 0.00% |
DOGZ | 1.48% | $614.77M | +1,372.26% | 0.00% |
VITL | -1.52% | $1.32B | +142.79% | 0.00% |
SYPR | 1.58% | $32.23M | -26.32% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HUSA | -22.20% | $16.69M | -11.56% | 0.00% |
MCK | -17.79% | $78.15B | +35.51% | 0.42% |
K | -8.48% | $27.77B | +52.50% | 2.79% |
MNR | -8.16% | $1.66B | -10.71% | 15.90% |
ASPS | -7.72% | $22.36M | -80.26% | 0.00% |
NFLX | -7.26% | $372.45B | +83.46% | 0.00% |
OXBR | -7.14% | $19.05M | +178.18% | 0.00% |
CBOE | -7.11% | $21.46B | +15.84% | 1.11% |
CYD | -5.25% | $364.46M | -2.94% | 4.26% |
TCTM | -5.20% | $8.10M | -42.99% | 0.00% |
TPST | -5.12% | $37.75M | -77.59% | 0.00% |
SRRK | -4.36% | $2.61B | +134.91% | 0.00% |
CME | -3.79% | $82.76B | +9.21% | 1.98% |
COR | -3.69% | $47.48B | +21.20% | 0.86% |
XGN | -3.53% | $62.26M | +127.74% | 0.00% |
VIRT | -3.41% | $3.17B | +110.38% | 2.60% |
FATBB | -3.33% | $81.94M | -12.91% | 11.69% |
RNR | -3.24% | $13.74B | +23.09% | 0.58% |
CLLS | -3.17% | $141.30M | -30.99% | 0.00% |
PGR | -2.51% | $149.10B | +57.29% | 0.45% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -41.92% | $388.04M | 1.43% |
VIXY | -38.14% | $195.31M | 0.85% |
TAIL | -30.55% | $67.98M | 0.59% |
USDU | -21.59% | $201.97M | 0.5% |
HIGH | -16.21% | $302.78M | 0.51% |
CTA | -14.83% | $350.27M | 0.78% |
UUP | -13.96% | $309.25M | 0.77% |
EQLS | -13.35% | $76.08M | 1% |
CORN | -11.02% | $61.12M | 0.2% |
WEAT | -9.03% | $120.27M | 0.28% |
SOYB | -7.58% | $27.32M | 0.22% |
KMLM | -7.23% | $353.87M | 0.9% |
HDRO | -6.95% | $164.26M | 0.3% |
UNG | -3.90% | $908.80M | 1.06% |
DBA | -3.75% | $755.88M | 0.93% |
DBO | -2.51% | $217.57M | 0.77% |
DBE | -2.25% | $50.13M | 0.77% |
KCCA | -1.88% | $220.51M | 0.87% |
IVOL | -0.44% | $548.70M | 1.02% |
COMT | -0.19% | $829.06M | 0.48% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BSCO | -0.10% | $2.35B | 0.1% |
AGZD | 0.14% | $142.76M | 0.23% |
COMT | -0.19% | $829.06M | 0.48% |
IVOL | -0.44% | $548.70M | 1.02% |
KRBN | 0.74% | $242.47M | 0.85% |
XHLF | 1.00% | $874.27M | 0.03% |
TBLL | 1.12% | $1.92B | 0.08% |
TBIL | 1.12% | $4.38B | 0.15% |
SGOV | 1.46% | $27.53B | 0.09% |
GSG | 1.52% | $914.42M | 0.75% |
CLOI | 1.84% | $715.40M | 0.4% |
KCCA | -1.88% | $220.51M | 0.87% |
DBE | -2.25% | $50.13M | 0.77% |
DBO | -2.51% | $217.57M | 0.77% |
BILZ | 2.55% | $563.02M | 0.14% |
USCI | 3.38% | $185.47M | 1.07% |
JUCY | 3.38% | $324.29M | 0.6% |
DFSD | 3.45% | $3.63B | 0.16% |
IBTE | 3.46% | $1.70B | 0.07% |
DBA | -3.75% | $755.88M | 0.93% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IVOV | 65.67% | $964.95M | 0.15% |
MDYV | 65.52% | $3.25B | 0.15% |
XJH | 65.20% | $248.84M | 0.12% |
RSPA | 65.18% | $273.87M | 0% |
IJJ | 65.08% | $8.03B | 0.18% |
EZM | 64.85% | $823.84M | 0.38% |
VBR | 64.79% | $32.03B | 0.07% |
MDY | 64.43% | $24.14B | 0.24% |
IJH | 64.39% | $95.89B | 0.05% |
JMEE | 64.30% | $1.51B | 0.24% |
SPMD | 64.27% | $12.03B | 0.03% |
SMMD | 64.23% | $1.24B | 0.15% |
IJR | 64.20% | $90.05B | 0.06% |
SPSM | 64.19% | $12.72B | 0.03% |
VAW | 64.08% | $3.00B | 0.1% |
DFUV | 63.85% | $11.68B | 0.21% |
IVOO | 63.79% | $2.38B | 0.1% |
DSTL | 63.64% | $2.02B | 0.39% |
VIOO | 63.60% | $3.12B | 0.1% |
ESML | 63.59% | $1.90B | 0.17% |